CVS Health (CVS)
(Delayed Data from NYSE)
$66.63 USD
-0.22 (-0.33%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $66.63 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
A Value D Growth C Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$66.63 USD
-0.22 (-0.33%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $66.63 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
A Value D Growth C Momentum B VGM
Zacks News
Has CVS Health (CVS) Outpaced Other Retail-Wholesale Stocks This Year?
by Zacks Equity Research
Is (CVS) Outperforming Other Retail-Wholesale Stocks This Year?
6 Promising Price-to-Book Value Stocks to Buy Now
by Zacks Equity Research
P/B ratio is emerging as a convenient tool to identify low-priced stocks that have high growth prospects.
Pharmacies & Drug Stores Industry Outlook: Prospects Look Weak
by Zacks Equity Research
Pharmacy retailers are gradually realizing the growing market demand for Medicare plan options. This apart, they are aggressively emphasizing on chronic disease care and management.
Zacks.com featured highlights include: ArcBest, American Airlines, Cardinal, Century Aluminum and CVS
by Zacks Equity Research
Zacks.com featured highlights include: ArcBest, American Airlines, Cardinal, Century Aluminum and CVS
The Zacks Analyst Blog Highlights: UnitedHealth, CVS, General Electric, ExxonMobil and Stryker
by Zacks Equity Research
The Zacks Analyst Blog Highlights: UnitedHealth, CVS, General Electric, ExxonMobil and Stryker
Here's Why You Should Add CVS Health to Your Portfolio Now
by Zacks Equity Research
CVS Health (CVS) is optimistic about synergies from Aetna deal which will help create a robust platform to serve individuals better.
Is Deep Value ETF (DVP) a Strong ETF Right Now?
by Sweta Killa
Smart Beta ETF report for DVP
Should Value Investors Buy CVS Health (CVS) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
5 Broker Favorite Stocks to Watch Out For
by Zacks Equity Research
The task of designing one's portfolio to include potential outperformers is not an easy one. Broker advice is necessary to design a winning portfolio.
Top Analyst Reports for UnitedHealth, CVS Health & General Electric
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including UnitedHealth (UNH), CVS Health (CVS) and General Electric (GE).
CVS Health (CVS) Gains But Lags Market: What You Should Know
by Zacks Equity Research
CVS Health (CVS) closed the most recent trading day at $65.53, moving +0.52% from the previous trading session.
Amazon Posts Record-Breaking Holiday Sales: Time to Buy AMZN Stock?
by Benjamin Rains
Shares of Amazon (AMZN) popped 5% in morning trading the day after Christmas after the e-commerce powerhouse said that its customers made more purchases worldwide than ever before during the holiday season. The question now is should investors consider buying Amazon stock on the dip as we move into 2019?
5 Great Healthcare Stocks to Buy for 2019
by Swarup Gupta
Rapid innovation, major advances and an ageing population have managed to sustain the popularity of healthcare stocks.
CVS Health (CVS) Stock Moves -1.22%: What You Should Know
by Zacks Equity Research
In the latest trading session, CVS Health (CVS) closed at $62.92, marking a -1.22% move from the previous day.
Rite Aid (RAD) Stock Up on Q3 Earnings Beat, FY19 View Down
by Zacks Equity Research
Rite Aid's (RAD) top and bottom lines improve year over year. Also, earnings came ahead of the Zacks Consensus Estimate but sales lagged the same.
CVS Health (CVS) Stock Moves -1.66%: What You Should Know
by Zacks Equity Research
In the latest trading session, CVS Health (CVS) closed at $70.69, marking a -1.66% move from the previous day.
Buy Amazon (AMZN) Stock on the Dip Heading into 2019?
by Benjamin Rains
Amazon (AMZN) stock has fallen over 16% in the last three months as part of the larger market pullback driven by the likes of Apple (AAPL) and other giants. The company's days of 40% top-line growth might also be over. But let's dive into Amazon's overall business picture and outlook to see if investors should buy AMZN stock heading into 2019.
CVS Health Aetna Synergy Impressive, PBM Selling Season Solid
by Zacks Equity Research
CVS Health (CVS) estimates a $750-million earning from near-term synergies with low- to mid-single digit addition in the second year after the closure of Aetna transaction.
The Zacks Analyst Blog Highlights: UnitedHealth, Broadcom, CVS Health, FedEx and Oracle
by Zacks Equity Research
The Zacks Analyst Blog Highlights: UnitedHealth, Broadcom, CVS Health, FedEx and Oracle
Here's What to Expect from Facebook (FB) Stock in 2019
by Benjamin Rains
Facebook's (FB) 2018 might be a year investors want to forget. But the social media powerhouse will hopefully use it as a lesson to help move forward. The question now is what should we expect from Facebook in 2019?
Top Analyst Reports for UnitedHealth, Broadcom & CVS Health
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including UnitedHealth (UNH), Broadcom (AVGO) and CVS Health (CVS).
CVS Health (CVS) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
CVS Health (CVS) closed at $73.34 in the latest trading session, marking a -1.01% move from the prior day.
Why Is CVS Health (CVS) Up 0.2% Since Last Earnings Report?
by Zacks Equity Research
CVS Health (CVS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Mixed Trade War Signals, the Moonves Scandal, & CVS' Drug Price Plan
by Ryan McQueeney
Ryan McQueeney discusses the latest drama in the U.S.-China trade war, new developments in Les Moonves' departure from CBS, and a new drug pricing plan from pharmacy giant CVS.
CVS Health (CVS) Stock Moves -0.77%: What You Should Know
by Zacks Equity Research
CVS Health (CVS) closed at $78.91 in the latest trading session, marking a -0.77% move from the prior day.